Insider Transactions in Q2 2015 at Vyant Bio, Inc. (VYNT)
Insider Transaction List (Q2 2015)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2015
|
Raju S.K. Chaganti Director |
SELL
Open market or private sale
|
Direct |
5,296
-2.99%
|
$63,552
$12.0 P/Share
|
|
Jun 12
2015
|
Raju S.K. Chaganti Director |
SELL
Open market or private sale
|
Direct |
7,000
-3.8%
|
$84,000
$12.01 P/Share
|
|
Jun 11
2015
|
Raju S.K. Chaganti Director |
SELL
Open market or private sale
|
Direct |
15,900
-10.36%
|
$190,800
$12.05 P/Share
|
|
Jun 10
2015
|
Raju S.K. Chaganti Director |
SELL
Open market or private sale
|
Direct |
22,817
-12.95%
|
$273,804
$12.03 P/Share
|
|
Jun 09
2015
|
Raju S.K. Chaganti Director |
SELL
Open market or private sale
|
Direct |
7,737
-4.21%
|
$92,844
$12.01 P/Share
|
|
Jun 08
2015
|
Raju S.K. Chaganti Director |
SELL
Open market or private sale
|
Direct |
24,583
-13.36%
|
$294,996
$12.03 P/Share
|
|
May 29
2015
|
Steven Hepburn VP of Biopharma Marketing |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+50.0%
|
-
|
|
May 14
2015
|
Howard Mc Leod Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
May 14
2015
|
Geoffrey E. Harris Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+33.33%
|
-
|
|
May 14
2015
|
Geoffrey E. Harris Director |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$50,000
$10.79 P/Share
|
|
May 14
2015
|
John Pappajohn Director |
BUY
Open market or private purchase
|
Direct |
5,000
+0.33%
|
$50,000
$10.74 P/Share
|